Abstract
Carcinoma of the prostate is primarily a disease of old age, rarely occurring before the age of 50 but with increasing frequency with advancing age (1,2). In general this malignancy has a slow growth rate and as a result, the more aggresive and radical therapy, which would be justifiable in younger patients and in other diseases, has to be balanced against the potential improvement in both quality and quantity of life (3).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Mostofic F, Leestma J, Lower urinary tract and male genitalia. In: Pathology, Vol. I, 6th ed. Anderson W (ed), Mosby, St. Louis, p. 850, 1971.
Whitemore WF, jr, The natural history of prostatic cancer. Cancer 32: 1104, 1973.
Corriere JN, jr, Cornog JL, Murphy JJ, Prognosis in patients with carcinoma of the prostate. Cancer 25: 911, 1970.
Gleason DF, Histologic grading and clinical staging or prostatic cancer. In: Urologic Pathology: The prostate. Tannenbaum M (ed), Lea & Febiger, Philadelphia, p. 171, 1977.
McGowan DG, unpublished.
Bruchovsky N, Rennie P, Van Doorn E, Steroid receptors in cancer. Mod. Med. of Canada 31: 914, 1976.
DeSombre ER, Smith S, Block GE et al. Prediction of breast cancer response to endocrine therapy. Cancer Chemother. Rep. 58: 513, 1974.
Krohn KA, The search for a gamma-emitting estrogenic ligand. J. nucl. Med. 21: 593, 1980.
Rivenson A, Silverman J, The prostatic carcinoma in laboratory animals. Invest. Urol. 16: 468, 1979.
Tubis M, Endow JS, Bland WH, The preparation of 1311 labeled diethylstilbestrol diphosphate and its potential use in nuclear medicine. J. nucl. Med. 6: 184, 1967.
Mende T, Wollny G, Gens J, On the use of radioiodine-labeled diethylstilbestrol diphosphate as a scanning agent of the liver. Nucl. med. Comm. 3,1982 in press. See: Wollny G, Gens J, Mende T, Jahresbericht des Bereiches Kernchemis des ZFK Rossendorf, 340–60, 1977.
Flanagan RJ, Lently BC, McGowan DG, Wiebe LI, a-Halostilbenes related to diethylstilbestrol. J. rad. Chem. 65, 81, 1981.
Ediss C, McQuarrie SA, In-house design and construction.
Ullberg S, Bengtsson G, Autoradiographic distribution studies with natural estrogens, Acta endocr. 43: 75, 1963.
Eakins MN, Palmer AJ, Waters SL, Studies in the rat with 18F-4-fluoroestradiol and 18F-4-fluoro-oestrone as potential prostate scanning agents: comparison with 1251–2-iodo-oestradiol and 1251–2,4-diiodo-oestradiol. Int. J. appl. Radiat. Isotopes 30: 395, 1979.
McElvany KD, Katzenellebogen JA, Senderoff SG, Siegel BA, Welch MJ, Tissue distribution, clearance rates and radiation dosimetry of 16N(Br-77)-bromoestradiol-1713. J. nucl. Med. 22:19, 1981.
Gatley SJ, Shaughnessy WJ, Inhorn L, Lieberman LM, Studies with 17ß(167(125I) Iodo)-Estradiol, an estrogen receptor-binding radiopharmaceutical, in rats bearing mammary tumors. J. nucl. Med. 22: 459, 1981.
Mazaitis JK, Gibson RE, Kornai T, Eckelman WC, Francis B, Reba RC, Radioiodinated estrogen derivatives, J. nucl. Med. 21: 142, 1980.
Heiman DF, Senderoff SG, Katzenellebogen JA, Neeley RJ, Estrogen receptor based imaging agents. 1. Synthesis and receptor binding affinity of some aromatic and D-ring halogenated estrogens. J. med. Chem. 23: 994, 1980.
Dodds EC, Lawson W, Noble RL, Biological effects of the synthetic oestrogenic substance 4:4’-dihydroxy-a:diethylstilbene. Lancet 1: 1389, 1938.
Grundy J, Artificial estrogens. Chem. Rev. 57: 281, 1957.
Kornai T, Eckelman WC, Johnsonbaugh RE, Mazaitis A, Kubota H, Reba RC, Estrogen derivatives for the external localization of estrogen-dependent malignancy. J. nucl. Med. 18: 360, 1977.
Marberger H, Riedesel RD, Anderson DO, Malek LB, A comparative study of phosphatase activities of various human tissues. J. Urol. 75: 857, 1956.
Hawkins EF, Nijs M, Brassine C, Tagnon HJ, Steroid receptors in the human prostate. 1. Estradiol-17ß binding in human prostatic hypertrophy. Steroi 26: 458, 1975.
Bashirelahi N, O’Toole JH, Young JD, A specific 1713-estradiol receptor in human benign hypertrophic prostate. Biochem. Med. 15: 254, 1976.
Eckman P, Snochowski M, Dahlberg E, Bression D, Hogberg B, Gustafsson JA, Steroid receptor content in cytosol from normal and hyperplastic human prostates. J. clin. Endocr. Metab. 49: 205, 1979.
Fergusson JD, Castration and oestrogen therapy. In: Endocrine Therapy of malignant disease. Stoll BA (ed), Saunders, London, p. 247, 1972.
Noble RL, Hochachka B, King D, Spontaneous and estrogen produced tumors i Nb rats and their behavior after transplantation. Cancer Res. 35: 766, 197
Dunning WF, Prostatic cancer in the rat. Nat. Cancer Inst. Monograph, 12: 351, 1963.
Drago JR, Ikeda RM, Maurer RE, Goldman LB, Tesluk H, The Nb rat: prestati adenocarcinoma model. Invest. Urol. 16: 353, 1979.
Seman G, Meyers B, Bowen JM, Dmochowski L, Histology and ultrastructure o the R-3327 C-F transplantable prostate tumor of Copenhagen-Fisher rats. Invest. Urol. 16: 231, 1978.
Collins JM, Bagwell CB, Block NL, Claflin AJ, Orvin GL, Pollack A, Stover Flow cytometric monitoring of R3327 rat prostate carcinoma. Invest. Urol. 19: 8, 1981.
Heston WDW, Menon M, Tananis C, Walsh PC, Androgen, estrogen and progesterone receptors of the R3327 Copenhagen rat prostatic tumor. Cancer Lett 6: 45, 1979.
Ip MM, Milholland RJ, Rosen F, Functionality of estrogen receptor and Tamoxifen treatment of R3327 Dunning rat prostatic adenocarcinoma. Cancer Res. 40:2188, 1980.
Mende T, Wollny G, Gens J, Schubert J, Verteilung und kinetik von Diaethy= stilbostroldiphosphat(Cytonol) nach intravenoeser injektion. Europ. J. nu(Med. 4:133, 1979.
Mende T, Hennig K, Wollny G, Gens J, Experimentelle untersuchungen über d_ Verteilung von intravenoes injiziertem jodmarkiertem Cytonol (diaethylsti1 bostroldiphosphat). Z. Urol. u. Nephrol. 71: 529, 1978.
Tesone M. Chazenbalk GD, Ballejos G, Charreau EH, Estrogen receptor in rat pancreatic islets. J. Steroid Biochem. 11: 1309, 1979.
Dahlberg E, Snochowki M, Gustafsson JA, Comparison of the R-3327H rat prostatic adenocarcinoma to human benign prostatic hyperplasia and metastatic carcinoma of the prostate with regard to steroid hormone receptors. The prostate, 1: 61, 1980.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Martinus Nijhoff Publishers, The Hague
About this chapter
Cite this chapter
Wiebe, L.I., Flanagan, R.J., Gati, L., Lentle, B.C., McGowan, D.G. (1982). Localization of Radioiodinated Estrogenic Stilbenes in Normal and Neoplastic Rat Prostate. In: Cox, P.H. (eds) Progress in Radiopharmacology 3. Developments in Nuclear Medicine, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7669-6_16
Download citation
DOI: https://doi.org/10.1007/978-94-009-7669-6_16
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-7671-9
Online ISBN: 978-94-009-7669-6
eBook Packages: Springer Book Archive